nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—Etoposide—sarcoma	0.106	0.542	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—sarcoma	0.0896	0.458	CbGbCtD
Aminosalicylic Acid—PTGS2—periosteum—sarcoma	0.0108	0.0558	CbGeAlD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Mitoxantrone—sarcoma	0.00921	0.0418	CcSEcCtD
Aminosalicylic Acid—CHUK—hematopoietic system—sarcoma	0.00903	0.0467	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—sarcoma	0.00877	0.0453	CbGeAlD
Aminosalicylic Acid—CHUK—connective tissue—sarcoma	0.0087	0.045	CbGeAlD
Aminosalicylic Acid—PTGS2—leg—sarcoma	0.0086	0.0445	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—sarcoma	0.00785	0.0406	CbGeAlD
Aminosalicylic Acid—PTGS2—hindlimb—sarcoma	0.00768	0.0397	CbGeAlD
Aminosalicylic Acid—PTGS2—cartilage tissue—sarcoma	0.00756	0.0391	CbGeAlD
Aminosalicylic Acid—PTGS2—appendage—sarcoma	0.00659	0.0341	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—sarcoma	0.00636	0.0329	CbGeAlD
Aminosalicylic Acid—Eruption—Dactinomycin—sarcoma	0.00601	0.0273	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Thiotepa—sarcoma	0.00581	0.0263	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Thiotepa—sarcoma	0.00581	0.0263	CcSEcCtD
Aminosalicylic Acid—ALOX5—hematopoietic system—sarcoma	0.00509	0.0263	CbGeAlD
Aminosalicylic Acid—CHUK—testis—sarcoma	0.00495	0.0256	CbGeAlD
Aminosalicylic Acid—ALOX5—connective tissue—sarcoma	0.0049	0.0253	CbGeAlD
Aminosalicylic Acid—CHUK—liver—sarcoma	0.00468	0.0242	CbGeAlD
Aminosalicylic Acid—ALOX5—smooth muscle tissue—sarcoma	0.00448	0.0232	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Etoposide—sarcoma	0.00435	0.0197	CcSEcCtD
Aminosalicylic Acid—MPO—hematopoietic system—sarcoma	0.00431	0.0223	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—sarcoma	0.00416	0.0215	CbGeAlD
Aminosalicylic Acid—MPO—connective tissue—sarcoma	0.00415	0.0214	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—sarcoma	0.00398	0.0206	CbGeAlD
Aminosalicylic Acid—MPO—skin of body—sarcoma	0.00374	0.0194	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—sarcoma	0.00359	0.0186	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—sarcoma	0.00358	0.0185	CbGeAlD
Aminosalicylic Acid—Pericarditis—Epirubicin—sarcoma	0.00347	0.0157	CcSEcCtD
Aminosalicylic Acid—ALOX5—bone marrow—sarcoma	0.00326	0.0169	CbGeAlD
Aminosalicylic Acid—Pericarditis—Doxorubicin—sarcoma	0.00321	0.0146	CcSEcCtD
Aminosalicylic Acid—MPO—lymphoid tissue—sarcoma	0.00303	0.0157	CbGeAlD
Aminosalicylic Acid—ALOX5—testis—sarcoma	0.00279	0.0144	CbGeAlD
Aminosalicylic Acid—MPO—bone marrow—sarcoma	0.00276	0.0143	CbGeAlD
Aminosalicylic Acid—ALOX5—liver—sarcoma	0.00264	0.0136	CbGeAlD
Aminosalicylic Acid—Eruption—Epirubicin—sarcoma	0.00244	0.0111	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Epirubicin—sarcoma	0.00244	0.0111	CcSEcCtD
Aminosalicylic Acid—MPO—testis—sarcoma	0.00236	0.0122	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00234	0.0106	CcSEcCtD
Aminosalicylic Acid—PTGS2—myometrium—sarcoma	0.00227	0.0118	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Doxorubicin—sarcoma	0.00226	0.0102	CcSEcCtD
Aminosalicylic Acid—Eruption—Doxorubicin—sarcoma	0.00226	0.0102	CcSEcCtD
Aminosalicylic Acid—MPO—liver—sarcoma	0.00223	0.0115	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—sarcoma	0.00219	0.0113	CbGeAlD
Aminosalicylic Acid—PTGS1—seminal vesicle—sarcoma	0.00215	0.0111	CbGeAlD
Aminosalicylic Acid—PTGS2—seminal vesicle—sarcoma	0.00205	0.0106	CbGeAlD
Aminosalicylic Acid—PTGS1—hematopoietic system—sarcoma	0.00204	0.0106	CbGeAlD
Aminosalicylic Acid—Jaundice—Thiotepa—sarcoma	0.00203	0.00922	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Epirubicin—sarcoma	0.00203	0.0092	CcSEcCtD
Aminosalicylic Acid—ALOX5—lymph node—sarcoma	0.00202	0.0105	CbGeAlD
Aminosalicylic Acid—PTGS1—connective tissue—sarcoma	0.00197	0.0102	CbGeAlD
Aminosalicylic Acid—PTGS2—hematopoietic system—sarcoma	0.00195	0.0101	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Thiotepa—sarcoma	0.00195	0.00883	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Dactinomycin—sarcoma	0.00193	0.00876	CcSEcCtD
Aminosalicylic Acid—PTGS2—connective tissue—sarcoma	0.00188	0.00972	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Doxorubicin—sarcoma	0.00188	0.00851	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Vincristine—sarcoma	0.00188	0.00851	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Dactinomycin—sarcoma	0.00186	0.00843	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Thiotepa—sarcoma	0.00185	0.00839	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Thiotepa—sarcoma	0.00183	0.00832	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Mitoxantrone—sarcoma	0.00183	0.00829	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Vincristine—sarcoma	0.00181	0.00822	CcSEcCtD
Aminosalicylic Acid—PTGS1—smooth muscle tissue—sarcoma	0.0018	0.0093	CbGeAlD
Aminosalicylic Acid—PTGS1—skin of body—sarcoma	0.00178	0.00918	CbGeAlD
Aminosalicylic Acid—Jaundice—Mitoxantrone—sarcoma	0.00176	0.00796	CcSEcCtD
Aminosalicylic Acid—PTGS2—smooth muscle tissue—sarcoma	0.00172	0.00889	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—sarcoma	0.00171	0.00885	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—sarcoma	0.0017	0.00878	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Mitoxantrone—sarcoma	0.00168	0.00762	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vincristine—sarcoma	0.00164	0.00744	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Thiotepa—sarcoma	0.00163	0.00739	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vincristine—sarcoma	0.00163	0.00738	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Mitoxantrone—sarcoma	0.00162	0.00733	CcSEcCtD
Aminosalicylic Acid—PTGS1—cardiac atrium—sarcoma	0.00155	0.00802	CbGeAlD
Aminosalicylic Acid—PTGS1—uterus—sarcoma	0.00154	0.00798	CbGeAlD
Aminosalicylic Acid—Anaemia—Thiotepa—sarcoma	0.00151	0.00683	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—sarcoma	0.00149	0.00678	CcSEcCtD
Aminosalicylic Acid—PTGS2—uterus—sarcoma	0.00147	0.00763	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Etoposide—sarcoma	0.00147	0.00666	CcSEcCtD
Aminosalicylic Acid—Jaundice—Etoposide—sarcoma	0.00146	0.00662	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Thiotepa—sarcoma	0.00146	0.00662	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—sarcoma	0.00145	0.00657	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Etoposide—sarcoma	0.0014	0.00634	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Mitoxantrone—sarcoma	0.00138	0.00625	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00138	0.00625	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymphoid tissue—sarcoma	0.00137	0.00711	CbGeAlD
Aminosalicylic Acid—PTGS1—tendon—sarcoma	0.00135	0.00699	CbGeAlD
Aminosalicylic Acid—Anaemia—Vincristine—sarcoma	0.00134	0.00606	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Etoposide—sarcoma	0.00133	0.00602	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Etoposide—sarcoma	0.00132	0.00598	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Thiotepa—sarcoma	0.0013	0.00592	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Thiotepa—sarcoma	0.0013	0.00591	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mitoxantrone—sarcoma	0.0013	0.0059	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vincristine—sarcoma	0.00129	0.00587	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—sarcoma	0.00129	0.00586	CcSEcCtD
Aminosalicylic Acid—PTGS2—tendon—sarcoma	0.00129	0.00668	CbGeAlD
Aminosalicylic Acid—Skin disorder—Thiotepa—sarcoma	0.00129	0.00586	CcSEcCtD
Aminosalicylic Acid—Anorexia—Thiotepa—sarcoma	0.00127	0.00575	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mitoxantrone—sarcoma	0.00126	0.00571	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—sarcoma	0.00126	0.00571	CcSEcCtD
Aminosalicylic Acid—PTGS2—bone marrow—sarcoma	0.00125	0.00647	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Epirubicin—sarcoma	0.00122	0.00553	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vincristine—sarcoma	0.00116	0.00525	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Thiotepa—sarcoma	0.00116	0.00524	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—sarcoma	0.00115	0.00524	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vincristine—sarcoma	0.00115	0.00524	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Thiotepa—sarcoma	0.00115	0.00521	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—sarcoma	0.00115	0.00521	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Etoposide—sarcoma	0.00115	0.0052	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—sarcoma	0.00113	0.00513	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—sarcoma	0.00113	0.00511	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mitoxantrone—sarcoma	0.00112	0.0051	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vincristine—sarcoma	0.00112	0.0051	CcSEcCtD
Aminosalicylic Acid—PTGS1—testis—sarcoma	0.00112	0.00579	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—sarcoma	0.00112	0.00506	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mitoxantrone—sarcoma	0.00112	0.00506	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mitoxantrone—sarcoma	0.00109	0.00497	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00109	0.00494	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Thiotepa—sarcoma	0.00109	0.00493	CcSEcCtD
Aminosalicylic Acid—Anaemia—Etoposide—sarcoma	0.00108	0.00491	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—sarcoma	0.00108	0.0049	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00107	0.00485	CcSEcCtD
Aminosalicylic Acid—Urticaria—Thiotepa—sarcoma	0.00106	0.00479	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Thiotepa—sarcoma	0.00105	0.00477	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Thiotepa—sarcoma	0.00105	0.00477	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Etoposide—sarcoma	0.00105	0.00475	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—sarcoma	0.00105	0.00475	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—sarcoma	0.00104	0.00473	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—sarcoma	0.00104	0.00473	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—sarcoma	0.00103	0.00469	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vincristine—sarcoma	0.00103	0.00465	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vincristine—sarcoma	0.00102	0.00462	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—sarcoma	0.00101	0.00523	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00101	0.00457	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mitoxantrone—sarcoma	0.000998	0.00453	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00099	0.00449	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Thiotepa—sarcoma	0.00098	0.00445	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—sarcoma	0.000972	0.00441	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vincristine—sarcoma	0.000964	0.00437	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—sarcoma	0.000948	0.0043	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000939	0.00426	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Etoposide—sarcoma	0.000935	0.00424	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vincristine—sarcoma	0.000932	0.00423	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vincristine—sarcoma	0.000932	0.00423	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Etoposide—sarcoma	0.000928	0.00421	CcSEcCtD
Aminosalicylic Acid—Urticaria—Mitoxantrone—sarcoma	0.000912	0.00414	CcSEcCtD
Aminosalicylic Acid—Anorexia—Etoposide—sarcoma	0.000911	0.00413	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Thiotepa—sarcoma	0.00091	0.00413	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mitoxantrone—sarcoma	0.000908	0.00412	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mitoxantrone—sarcoma	0.000908	0.00412	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—sarcoma	0.000903	0.0041	CcSEcCtD
Aminosalicylic Acid—Dizziness—Thiotepa—sarcoma	0.000879	0.00399	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—sarcoma	0.000877	0.00398	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—sarcoma	0.000869	0.00394	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—sarcoma	0.000852	0.00386	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mitoxantrone—sarcoma	0.000846	0.00384	CcSEcCtD
Aminosalicylic Acid—Vomiting—Thiotepa—sarcoma	0.000846	0.00384	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dactinomycin—sarcoma	0.000839	0.00381	CcSEcCtD
Aminosalicylic Acid—Rash—Thiotepa—sarcoma	0.000839	0.0038	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Thiotepa—sarcoma	0.000838	0.0038	CcSEcCtD
Aminosalicylic Acid—Headache—Thiotepa—sarcoma	0.000833	0.00378	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—sarcoma	0.000832	0.00378	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Etoposide—sarcoma	0.00083	0.00377	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—sarcoma	0.000825	0.00374	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—sarcoma	0.000823	0.00373	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—sarcoma	0.000818	0.00371	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—sarcoma	0.000811	0.0042	CbGeAlD
Aminosalicylic Acid—Diarrhoea—Vincristine—sarcoma	0.000807	0.00366	CcSEcCtD
Aminosalicylic Acid—Nausea—Thiotepa—sarcoma	0.00079	0.00358	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—sarcoma	0.000788	0.00358	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mitoxantrone—sarcoma	0.000786	0.00356	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—sarcoma	0.000784	0.00356	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—sarcoma	0.000784	0.00355	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—sarcoma	0.000781	0.00354	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—sarcoma	0.00078	0.00354	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymph node—sarcoma	0.000776	0.00401	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—sarcoma	0.000762	0.00345	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—sarcoma	0.000759	0.00344	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—sarcoma	0.000757	0.00344	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—sarcoma	0.000755	0.00343	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Etoposide—sarcoma	0.000755	0.00343	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—sarcoma	0.000754	0.00342	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—sarcoma	0.00075	0.0034	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—sarcoma	0.000744	0.00338	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—sarcoma	0.000744	0.00337	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—sarcoma	0.000743	0.00337	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—sarcoma	0.000739	0.00335	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—sarcoma	0.000739	0.00335	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mitoxantrone—sarcoma	0.00073	0.00331	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—sarcoma	0.000725	0.00329	CcSEcCtD
Aminosalicylic Acid—Rash—Mitoxantrone—sarcoma	0.000724	0.00329	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mitoxantrone—sarcoma	0.000723	0.00328	CcSEcCtD
Aminosalicylic Acid—Headache—Mitoxantrone—sarcoma	0.000719	0.00326	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etoposide—sarcoma	0.000704	0.00319	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—sarcoma	0.0007	0.00318	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—sarcoma	0.000697	0.00316	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—sarcoma	0.000689	0.00312	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—sarcoma	0.000684	0.0031	CcSEcCtD
Aminosalicylic Acid—Nausea—Mitoxantrone—sarcoma	0.000682	0.00309	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—sarcoma	0.000656	0.00298	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—sarcoma	0.000654	0.00297	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—sarcoma	0.000647	0.00293	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—sarcoma	0.000643	0.00291	CcSEcCtD
Aminosalicylic Acid—Dizziness—Etoposide—sarcoma	0.000632	0.00287	CcSEcCtD
Aminosalicylic Acid—Vomiting—Etoposide—sarcoma	0.000607	0.00276	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—sarcoma	0.000607	0.00275	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—sarcoma	0.000606	0.00275	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—sarcoma	0.000602	0.00273	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—sarcoma	0.000602	0.00273	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—sarcoma	0.000598	0.00271	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—sarcoma	0.000598	0.00271	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—sarcoma	0.000595	0.0027	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—sarcoma	0.000587	0.00266	CcSEcCtD
Aminosalicylic Acid—Nausea—Etoposide—sarcoma	0.000567	0.00257	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—sarcoma	0.000561	0.00255	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000555	0.00252	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—sarcoma	0.000543	0.00247	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—sarcoma	0.000525	0.00238	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—sarcoma	0.000524	0.00238	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—sarcoma	0.00052	0.00236	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000513	0.00233	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—sarcoma	0.00051	0.00232	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—sarcoma	0.000486	0.0022	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—sarcoma	0.000485	0.0022	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—sarcoma	0.000481	0.00218	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—sarcoma	0.000472	0.00214	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—sarcoma	0.000465	0.00211	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—sarcoma	0.000462	0.0021	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—sarcoma	0.000438	0.00199	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—sarcoma	0.000431	0.00195	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000428	0.00194	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—sarcoma	0.000425	0.00193	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—sarcoma	0.000423	0.00192	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—sarcoma	0.000423	0.00192	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—sarcoma	0.000405	0.00184	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—sarcoma	0.000395	0.00179	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—sarcoma	0.000394	0.00179	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—sarcoma	0.000392	0.00178	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—sarcoma	0.000392	0.00178	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—KRAS—sarcoma	0.000377	0.000966	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000376	0.000963	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—HRAS—sarcoma	0.000371	0.00095	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000371	0.000949	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	0.000369	0.000944	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—SRC—sarcoma	0.000368	0.000943	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Epirubicin—sarcoma	0.000366	0.00166	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—sarcoma	0.000365	0.00166	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—HRAS—sarcoma	0.000365	0.000934	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—MDM2—sarcoma	0.000364	0.000933	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—SRC—sarcoma	0.000362	0.000927	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000359	0.00092	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PLCG1—sarcoma	0.000359	0.00092	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—NRAS—sarcoma	0.000354	0.000907	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Epirubicin—sarcoma	0.000354	0.00161	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTPRC—sarcoma	0.000353	0.000903	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—HRAS—sarcoma	0.00035	0.000895	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—sarcoma	0.000349	0.000893	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PLCG1—sarcoma	0.000345	0.000883	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—JUN—sarcoma	0.000342	0.000876	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ATF1—sarcoma	0.000341	0.000874	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KIT—sarcoma	0.000341	0.000872	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Epirubicin—sarcoma	0.00034	0.00154	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.00034	0.000869	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—NRAS—sarcoma	0.000339	0.000868	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—sarcoma	0.000339	0.00154	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—sarcoma	0.000338	0.00153	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—sarcoma	0.000337	0.00153	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—sarcoma	0.000335	0.00152	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—NRAS—sarcoma	0.000334	0.000854	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—SRC—sarcoma	0.000331	0.000848	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—SRC—sarcoma	0.00033	0.000844	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ENO2—sarcoma	0.000328	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—SRC—sarcoma	0.000328	0.00084	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Doxorubicin—sarcoma	0.000328	0.00149	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism—HBA1—sarcoma	0.000326	0.000835	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CREB1—sarcoma	0.000324	0.00083	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—sarcoma	0.000323	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000323	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000322	0.000824	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—HRAS—sarcoma	0.000321	0.000821	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.00032	0.000818	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—NRAS—sarcoma	0.000319	0.000816	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Epirubicin—sarcoma	0.000318	0.00144	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	0.000318	0.000813	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—NRAS—sarcoma	0.000317	0.000812	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—NRAS—sarcoma	0.000316	0.000808	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Doxorubicin—sarcoma	0.000315	0.00143	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 signaling—NRAS—sarcoma	0.000314	0.000804	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000312	0.0008	CbGpPWpGaD
Aminosalicylic Acid—Rash—Doxorubicin—sarcoma	0.000312	0.00142	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—sarcoma	0.000312	0.00142	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—sarcoma	0.00031	0.00141	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—sarcoma	0.000309	0.000792	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—sarcoma	0.000309	0.000791	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—SRC—sarcoma	0.000307	0.000786	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000306	0.000782	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—KRAS—sarcoma	0.000305	0.000781	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—SRC—sarcoma	0.000304	0.000779	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—sarcoma	0.000304	0.000778	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—SRC—sarcoma	0.000302	0.000772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—SRC—sarcoma	0.0003	0.000769	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—sarcoma	0.000296	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD34—sarcoma	0.000296	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—sarcoma	0.000295	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—NRAS—sarcoma	0.000295	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—NRAS—sarcoma	0.000295	0.000756	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Doxorubicin—sarcoma	0.000294	0.00134	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR—NRAS—sarcoma	0.000293	0.000749	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—KRAS—sarcoma	0.000292	0.000747	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TLE1—sarcoma	0.000291	0.000746	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—sarcoma	0.00029	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—NRAS—sarcoma	0.00029	0.000743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000289	0.00074	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—sarcoma	0.000289	0.000739	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—NRAS—sarcoma	0.000289	0.000739	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000289	0.000739	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—sarcoma	0.000288	0.000738	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—sarcoma	0.000287	0.000736	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—KRAS—sarcoma	0.000287	0.000735	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—sarcoma	0.000286	0.000732	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—sarcoma	0.000282	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000281	0.00072	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—sarcoma	0.000281	0.000719	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLCG1—sarcoma	0.000278	0.000713	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—KRAS—sarcoma	0.000274	0.000702	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	0.000273	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NRAS—sarcoma	0.000273	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—KRAS—sarcoma	0.000273	0.000699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	0.000272	0.000696	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—KRAS—sarcoma	0.000272	0.000695	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—KRAS—sarcoma	0.00027	0.000692	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—sarcoma	0.000269	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—sarcoma	0.000269	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—sarcoma	0.000269	0.000689	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MDM2—sarcoma	0.000268	0.000687	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—sarcoma	0.000267	0.000683	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	0.000266	0.000682	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000265	0.000679	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—sarcoma	0.000264	0.000677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—sarcoma	0.000263	0.000674	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NPM1—sarcoma	0.000263	0.000673	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	0.000262	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—sarcoma	0.000259	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000259	0.000663	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000257	0.000657	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FOXO1—sarcoma	0.000255	0.000653	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—sarcoma	0.000255	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PDGFRB—sarcoma	0.000255	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000254	0.000651	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KRAS—sarcoma	0.000254	0.000651	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KRAS—sarcoma	0.000254	0.000651	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000253	0.000648	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KRAS—sarcoma	0.000252	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PDGFRA—sarcoma	0.000251	0.000641	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KRAS—sarcoma	0.00025	0.000639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—sarcoma	0.000249	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KRAS—sarcoma	0.000249	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—sarcoma	0.000248	0.000635	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FOXO1—sarcoma	0.000245	0.000627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PDGFRB—sarcoma	0.000244	0.000626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—sarcoma	0.000244	0.000625	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—sarcoma	0.000244	0.000624	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PDGFRA—sarcoma	0.000241	0.000616	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000239	0.000612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	0.000238	0.00061	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KRAS—sarcoma	0.000235	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—sarcoma	0.000233	0.000597	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	0.000232	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—sarcoma	0.000232	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—sarcoma	0.000231	0.000591	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—sarcoma	0.00023	0.000588	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO2—sarcoma	0.000228	0.000583	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000226	0.00058	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—sarcoma	0.000225	0.000577	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000225	0.000576	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—sarcoma	0.00022	0.000564	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000219	0.000562	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000216	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—sarcoma	0.000216	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—sarcoma	0.000216	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—sarcoma	0.000214	0.000548	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPRC—sarcoma	0.000214	0.000547	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000213	0.000544	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000212	0.000543	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—sarcoma	0.000211	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PLCG1—sarcoma	0.000209	0.000536	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—SRC—sarcoma	0.000209	0.000535	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—sarcoma	0.000205	0.000524	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TLE1—sarcoma	0.000204	0.000522	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—sarcoma	0.000201	0.000515	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—sarcoma	0.0002	0.000512	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ATF1—sarcoma	0.000199	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KIT—sarcoma	0.000194	0.000497	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PLCG1—sarcoma	0.000193	0.000495	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000191	0.00049	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000191	0.000489	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000191	0.000488	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000189	0.000485	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIT—sarcoma	0.000187	0.000478	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CXCR4—sarcoma	0.000186	0.000475	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—sarcoma	0.000185	0.000474	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CREB1—sarcoma	0.000185	0.000473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—sarcoma	0.000183	0.000469	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CREB1—sarcoma	0.000178	0.000455	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—sarcoma	0.000176	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—sarcoma	0.000173	0.000443	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TLE1—sarcoma	0.000173	0.000442	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFC—sarcoma	0.000172	0.000441	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000171	0.000438	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000167	0.000427	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NPM1—sarcoma	0.000156	0.000399	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000153	0.000393	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MDM2—sarcoma	0.000153	0.000392	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.00015	0.000384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—sarcoma	0.00015	0.000383	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FOXO1—sarcoma	0.000149	0.00038	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFRB—sarcoma	0.000148	0.000379	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—sarcoma	0.000147	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MDM2—sarcoma	0.000147	0.000376	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDGFRA—sarcoma	0.000146	0.000374	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO2—sarcoma	0.000142	0.000364	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000142	0.000363	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HBA1—sarcoma	0.000141	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FLT1—sarcoma	0.000138	0.000352	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FOXO1—sarcoma	0.000137	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFRB—sarcoma	0.000137	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLCG1—sarcoma	0.000135	0.000346	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO2—sarcoma	0.000135	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PDGFRA—sarcoma	0.000135	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—JUN—sarcoma	0.000133	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—sarcoma	0.000132	0.000338	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR4—sarcoma	0.00013	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ATF1—sarcoma	0.000129	0.000329	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000126	0.000322	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLCG1—sarcoma	0.000121	0.000309	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SRC—sarcoma	0.000119	0.000305	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—sarcoma	0.000115	0.000294	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SRC—sarcoma	0.000115	0.000293	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PLCG1—sarcoma	0.000114	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIT—sarcoma	0.000113	0.00029	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO2—sarcoma	0.000113	0.000289	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HBA1—sarcoma	0.000112	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—sarcoma	0.00011	0.000282	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CXCR4—sarcoma	0.00011	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CREB1—sarcoma	0.000108	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—sarcoma	0.000105	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—sarcoma	0.000104	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—sarcoma	0.000101	0.000258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—sarcoma	0.0001	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CREB1—sarcoma	9.94e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—sarcoma	9.88e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FOXO1—sarcoma	9.6e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLCG1—sarcoma	9.59e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRB—sarcoma	9.58e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—sarcoma	9.49e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRA—sarcoma	9.44e-05	0.000242	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—sarcoma	8.91e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—sarcoma	8.4e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—sarcoma	8.23e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FOXO1—sarcoma	8.12e-05	0.000208	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRB—sarcoma	8.11e-05	0.000208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—sarcoma	8.06e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRA—sarcoma	7.98e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—sarcoma	7.96e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—sarcoma	7.94e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—sarcoma	7.75e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—sarcoma	7.69e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—sarcoma	7.32e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—sarcoma	7.1e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CREB1—sarcoma	6.96e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—sarcoma	6.95e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—sarcoma	6.68e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—sarcoma	6.42e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—sarcoma	6.19e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—sarcoma	6.17e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—sarcoma	6.09e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CREB1—sarcoma	5.89e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—sarcoma	5.76e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—sarcoma	5.75e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—sarcoma	5.75e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—sarcoma	5.62e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—sarcoma	5.31e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—sarcoma	5.15e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—sarcoma	5.02e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—sarcoma	5.01e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—sarcoma	4.97e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—sarcoma	4.89e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—sarcoma	4.87e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—sarcoma	4.52e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—sarcoma	4.49e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—sarcoma	4.38e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—sarcoma	4.32e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—sarcoma	4.2e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—sarcoma	4.03e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—sarcoma	3.94e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—sarcoma	3.8e-05	9.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—sarcoma	3.72e-05	9.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—sarcoma	3.66e-05	9.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—sarcoma	3.41e-05	8.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—sarcoma	3.33e-05	8.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—sarcoma	3.31e-05	8.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—sarcoma	3.16e-05	8.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—sarcoma	3.15e-05	8.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—sarcoma	2.67e-05	6.85e-05	CbGpPWpGaD
